ORTEXORTEX News
Tracking INFY? Get live short interest, options flow, and signals on ORTEX.Sign up free →
IN
Earnings PreviewINFY

INFY Borrow Tightens to a 52-Week Extreme Before Thursday's Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 20 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

INFY heads into its October 23 results with the borrow market sending an unusually sharp pre-earnings signal.

The most striking development in the lending market is how abruptly availability has collapsed. With availability now at just 1.57% of shares already borrowed, the borrow pool is essentially fully used, the tightest it has been all year. That compares with availability around 36% as recently as late September. The drop accelerated through the first two weeks of October, suggesting a deliberate build-up of short positioning ahead of the print rather than gradual drift. Short interest itself has pulled back about 13% over the past week to roughly 114 million shares, yet the borrow market tells a different story: whoever holds those positions is not returning stock, and new supply has dried up. Cost to borrow has eased from a recent peak above 2.3% but remains elevated relative to its September lows. The stock itself has rebounded sharply, up around 12.6% over the past week and 12.7% over the past month, to close at $12.20 on Monday, a rally that may itself be fuelling fresh hedging demand.

Options positioning reinforces the defensive lean. The put/call ratio jumped to 2.76 on Monday, 2.6 standard deviations above its 20-day average of 2.07, and while that average is already elevated by most standards, the single-session spike to the highest level since the 52-week peak of 3.53 stands out. Investors are paying a clear premium for downside protection heading into Thursday, even after a week in which the stock regained significant ground.

The analyst community is not particularly enthusiastic, and the recent moves are too old to treat as fresh signals. The bulk of the post-results revisions were filed on July 24, after Q1 results, when JP Morgan downgraded to Neutral from Overweight and cut its target from $12.70 to $10.90, and HSBC moved to Hold from Buy. Several other firms held ratings but trimmed targets. The consensus mean target now sits at around $11.67, below the current price of $12.20, a rare configuration that implies the Street as a whole is not chasing the recent rally. The bull case centres on margin resilience, a $3.6 billion deal pipeline, and diversified global exposure. Bears point to the Q2 guidance cut, client deferrals, AI-driven erosion of legacy managed-services volumes, and specific client losses in European autos and energy that have yet to fully cycle through reported numbers. EPS momentum ranks in the bottom quartile of the universe over both 30 and 90 days, while the forward earnings growth estimate has contracted sharply year on year.

The ORTEX short score has moderated to 56.5 from above 60 in early October, consistent with some short covering into the rally but not a wholesale retreat. There is no measured alternative data lead available for this print, so the debate rests squarely on what management says about the trajectory of deal conversion and whether the FY27 guidance range survives contact with a second consecutive quarter of cautious commentary.

Thursday's print tests whether the sharp price recovery of the past month reflects genuine demand stabilisation or simply a relief bounce that the company's own numbers will struggle to validate.

Stocks in this article

See the live data behind this article on ORTEX.

Open INFY on ORTEX →

How this article was generated

Generated
20 Oct 2026, 04:06
Data as of
20 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.